<DOC>
	<DOC>NCT00195559</DOC>
	<brief_summary>The purpose of this study is to determine whether Levonorgestrel/Ethinyl Estradiol (LNG/EE) is effective in treating the symptoms of severe Premenstrual Dysphoric Disorder.</brief_summary>
	<brief_title>Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder</brief_title>
	<detailed_description />
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Premenstrual Dysphoric Disorder</mesh_term>
	<mesh_term>Menstruation Disturbances</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Generally healthy, women aged 18 to 49 years. History of severe PMS symptoms over the last year, as determined by the investigator. Regular 21 to 35 day menstrual cycle for 2 months prior to first study visit. Major depressive disorder requiring antidepressant treatment or hospitalization within the last 3 years. Contraindication to combination oral contraceptives. Use of antidepressants/anxiolytics within 10 days of screening and for the duration of the study. Other exclusion applies.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Premenstrual Syndrome (PMS)</keyword>
	<keyword>Hormone Therapy</keyword>
</DOC>